N/A
93.384
The purpose of this program is to coordinate the acceleration of biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone by – (A) facilitating collaboration between Advance Research Projects Agency for Health and other Federal agencies, relevant industries, academia, and other persons, with respect to advance high-potential, high impact biomedical and health research that cannot be readily accomplished through traditional research and commercial activity; (B) identifying and promoting revolutionary advanced in health sciences; (C) promoting high reward innovation to develop high need cures (D) ensuring that the United States maintains, global leadership and science and innovation and the highest quality of life and health for its citizens.
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.